Literature DB >> 35143590

Stress and substance abuse among workers during the COVID-19 pandemic in an intensive care unit: A cross-sectional study.

Diego Vinicius Santinelli Pestana1, Dante Raglione1, Luiz Dalfior Junior1, Caroline de Souza Pereira Liberatti1, Elisangela Camargo Braga1, Vitor Augusto de Lima Ezequiel1, Adriana da Silva Alves1, Juliana Gil Mauro1, José Omar de Araújo Dias1, Paulo Thadeu Fantinato Moreira1, Bruno Del Bianco Madureira1, Lilian Petroni Paiva1, Bruno Melo Nóbrega de Lucena1, João Manoel Silva Junior1, Luiz Marcelo Sá Malbouisson1.   

Abstract

OBJECTIVE: Professionals working in intensive care units (ICUs) during the COVID-19 pandemic have been exposed to stressful situations and increased workload. The association between symptoms of traumatic stress disorders, substance abuse and personal/occupational characteristics of Brazilian COVID-19-ICU workers is still to be addressed. Our aim was to evaluate the prevalence of those conditions and to find if those associations exist.
METHODS: In this observational, single-center, cross-sectional study, all professionals working in a COVID-19 ICU were invited to fill an anonymous form containing screening tools for traumatic stress disorders and substance abuse, and a section with questions regarding personal and occupational information.
RESULTS: Three hundred seventy-six ICU professionals participated. Direct exposure to patients infected by COVID-19, history of relatives infected by COVID-19, and sex (female) were significantly associated with signs and symptoms of traumatic stress disorders. 76.5% of the participants had scores compatible with a diagnosis of traumatic stress disorders. Moreover, the prevalence of scores suggestive of Tobacco and Alcohol abuse were 11.7% and 24.7%, respectively.
CONCLUSION: ICU workers had significantly elevated scores on both screening forms. Providing psycho-social support to ICU professionals may prevent future problems with traumatic stress disorders or substance abuse.

Entities:  

Mesh:

Year:  2022        PMID: 35143590      PMCID: PMC8830709          DOI: 10.1371/journal.pone.0263892

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

As the COVID-19 pandemic progresses, several hospitals have gone through changes in their usual work dynamics, among which are the elevated demand for intensive care unit (ICU) beds, the increased death rate, and preventive measures to avoid infection during healthcare. All of those elements are present in the daily routine of the ICU staff, interfering with their mental and physical health. Those factors may lead to increased workload and stress, therefore enhancing the risk of developing acute or chronic psychological disturbances (e.g., burnout, substance abuse [SA], acute stress disorder [ASD], and post-traumatic stress disorder [PTSD]) [1-4]. Even in non-pandemic periods, healthcare professionals working in ICUs suffer high stress loads possibly due to the environment and the severity of patients [5]. In this context, recurrent stressful stimuli may lead the professionals developing SA [6, 7] and ASD [8], more often than in other areas of healthcare [9-11]. Additionally, recent studies suggest those workers have been experiencing a high impact in their mental health during the pandemic [12, 13]. However, limited research has been conducted on the occurrence of those phenomena in healthcare professionals working in Brazilian ICUs during the COVID-19 pandemic. Furthermore, there is no data providing an independent analysis of the eventual associations between each single stressor element that may be present in the ICU environment and the occurrence of SA, PTSD, and ASD in that population [14]. Therefore, the aim of this study was to evaluate the occurrence of SA, PTSD, and ASD in professionals working in Brazilian ICUs, either having direct contact with patients or not, using validated questionnaires as tools to assess the prevalence of those conditions. The secondary objective was to identify associations between epidemiological and labor characteristics of those workers and the development of those psychological disturbances in that population.

Methods

Study design

This was an observational, single-center, cross-sectional, online questionnaire-based study. This study was carried out in an intensive care unit in an oncological hospital in São Paulo, Brazil.

Study participants

All the professionals working in an oncological COVID-19 ICU, regardless of their role (health professionals and non-health professionals), who were on duty for at least during one shift through the period of July to October/2020, were invited to participate in this study. Exclusion criteria were as follows: age under 18, refusal to participate or to sign written informed consent, and being part of the group that contributed to the organization of this study. Additionally, those who were absent from work during the data collection period were excluded, regardless of the reason for absence (e.g., vacations, medical leave). All participants received a standardized approach. The study was approved by institutional ethics committees. All participants filled the questionnaires after signing the consent form during one of their work shifts, without interruptions. This project followed the guidelines of the Declaration of Helsinki.

Approach to participants

To avoid constraints and exposure, all participants were approached and invited to participate individually. A reserved, isolated room was always offered, and the participants could use it while filling the online forms. Participants from all shifts and sections working in the COVID-19 ICU were invited. All answers were kept private and anonymous, and were obtained in one visit.

Measurements

Participants filled a standardized form containing personal and professional information (see Supporting Information section); they also answered screening forms for SA (Alcohol Smoking and Substance Involvement Screening Test [ASSIST 2.0]) [15, 16], ASD, and PTSD (using the Impact of Events Scale-Revised [IES-R]) [17, 18]. The IES-R scores were categorized as follows: 1–11 = few/no signs of ASD/PTSD; 12–32 = several signs of ASD/PTSD, patient monitoring is recommended; ≥33 = highly suggestive of ASD/PTSD, immediate psychiatric evaluation is recommended [17]. The ASSIST 2.0 scores were categorized as follows: 0–3 = occasional substance use; 4–15 = suggestive of substance abuse; ≥16 = suggestive of substance dependence [15]. The ASSIST 2.0 provided separate scores for each substance category. Frequencies were calculated and associations between the participants characteristics and the results of the questionnaires were made. Questionnaires were made available as Supporting Information S1–S6 Files.

Statistical analysis

Categorical variables were expressed in frequencies. The Quantitative variables were classified according to normal or non-normal distribution using Shapiro-Wilk’s test and were expressed with mean and standard deviation or median and interquartile range. The means of continuous variables with normal distribution were compared using Student T test for independent variables. The medians of continuous variables with non-normal distribution were compared using Mann-Whitney’s U test. Categorical variables were compared using Chi-square test or Fisher’s exact test when indicated. When appropriate, multivariate logistic regression analyses were used to explore the relationship among variables, calculating measures of association among variables expressed by odds ratio and a 95% confidence interval. Moreover, the regression analyses were used to adjust eventual confounding factors given the variable number of participants according to different specialties and roles in the ICU. All tests were two-sided. Values of p<0.05 were considered statistically significant. All statistical analyses were performed using STATA/MP Version, 16.1 (for MAC) (StataCorp. 2019. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC).

Results

Three hundred seventy-six ICU professionals agreed to participate in this survey, 340 with direct exposure to COVID-19 infected patients (see Table 1). Professionals directly exposed to infected patients included 54 physicians (14%), 53 physiotherapists (14%), 226 nurses/technicians (60%), 38 pharmacists (10%), 5 nutritionists (1%), 7 psychologists (1.5%) and 3 social service professionals (0.7%). 71.5% of the participants were female. The age variable was categorized, and participants who were less than 38 years of age were the most frequent (56.4%). More than 80% of the workers who were directly exposed participated in this study. It was not possible to determine the answer ratio among workers without direct exposure as most of them (e.g., security, cleaning services) were employed by third-party companies. Less than ten individuals refused to participate.
Table 1

Socio demographic, personal, and occupational characteristics of participants.

Baseline characteristicICU professionals
n %
Gender 
    Female26971.5
    Male10728.5
Age*  
    > 38 years of age16143.6 
    < 38 years of age21556.4
Occupational exposure to infected patients (exposed)34090.6
Time exposed to infected patients  
    Non-exposed3910.4
    Less than 24h/week8723.1
    Over 24h/week25066.5
History of psychiatric diseasesa4311.5
Infected by COVID-19a18750.0
Relative infected by COVID-19a14338.0
Living with high-risk group relatives for COVID-19a24063.8
Sought alternative accommodation away from homea8021.3

Note. N = 376 (total number of participants); n = number of participants within the subgroup; ICU = Intensive Care Unit.

*Age groups were categorized and ages <38 years of age were the most frequent.

a Reflects the number and percentage of participants answering “yes” to this question.

Note. N = 376 (total number of participants); n = number of participants within the subgroup; ICU = Intensive Care Unit. *Age groups were categorized and ages <38 years of age were the most frequent. a Reflects the number and percentage of participants answering “yes” to this question. Most participants (66.5%) had a weekly exposure greater than 24 hours. 50% of the participants had been infected by COVID-19, and 38% of them had had a relative infected. Although most of them shared their homes with individuals from vulnerable populations (e.g., elderly relatives), only 21% of them sought alternative accommodation away from home during the pandemic. Forty-three participants (11.5%) declared to have a history of psychiatric disease. Table 1 describes the characteristics of the studied individuals.

IES-R score results

Most participants (76.3%) had scores ≥12 (see Table 2). One-hundred twenty-seven (33.8%) of them had scores higher than 33, which strongly suggests a diagnosis of PTSD and the need of psychiatric evaluation as soon as possible. Eighty-nine (23.7%) participants were free from PTSD signs or only had a few of them. Results are summarized on Table 2.
Table 2

Frequencies of IES-R score categories.

Score CategoriesICU professionals
n %
1–118923.7
12–3216042.5
≥3312733.8

Note. N = 376 (total number of participants); n = number of participants within the subgroup.

Mean IES-R score = 26.6, Standard Deviation = 17.9

IES-R = Impact of Event Scale–Revised; scores were categorized according to the clinical interpretation of the results.

*Categories: 1–11 = few/no signs of traumatic stress disorder, 12–32 = several signs of traumatic disorder, patient follow up is recommended, >33 = high probability of ongoing traumatic stress disorder, immediate psychiatric evaluation is recommended [17].

Note. N = 376 (total number of participants); n = number of participants within the subgroup. Mean IES-R score = 26.6, Standard Deviation = 17.9 IES-R = Impact of Event Scale–Revised; scores were categorized according to the clinical interpretation of the results. *Categories: 1–11 = few/no signs of traumatic stress disorder, 12–32 = several signs of traumatic disorder, patient follow up is recommended, >33 = high probability of ongoing traumatic stress disorder, immediate psychiatric evaluation is recommended [17].

Psychiatric medical history

The relationship between IES-R scores and history of psychiatric disease was assessed, but those factors did not present a statistically significant association (p = 0.341, OR = 2.68 [95% CI = 0.35–20.51]) (see Table 3). Then, the relationship between IES-R scores and history of anxiety disorders (which included ASD and PTSD) was assessed, but those factors also did not present a statistically significant association (p = 0.44, OR = 2.23 [95% CI = 0.29–17.13]). Table 3 summarizes those findings.
Table 3

Factors without an association with IES-R scores.

Logistic parameterIES-R scores
  OR CI p
History of psychiatric disease2.680.35–20.510.341
History of anxiety disorders2.230.29–17.130.44
Sought alternative accommodation away from home5.720.75–43.320.091

Note. OR = Odds Ratio, CI = 95% confidence interval, IES-R = Impact of Event Scale–Revised.

Note. OR = Odds Ratio, CI = 95% confidence interval, IES-R = Impact of Event Scale–Revised.

Personal and occupational factors

Among personal factors, being a female and having a relative infected by COVID-19 were associated with higher IES-R scores (Table 4). When compared to men, women had a higher median score (27 vs 19 in males [p = 0.0001]) even after adjustment with Wilcoxon rank sum test. Professionals with infected relatives (OR = 3.91 [p = 0.031, 95% CI = 1.13–13.50]) were also significantly more likely to score higher in the IES-R, therefore more likely to suffer from PTSD or ASD (Table 4). The relationship between those who had sought alternative accommodation away from home during the pandemic in order to protect their relatives and IES-R scores was also assessed, but it was not statistically significant (OR = 5.72 [p = 0.091, 95% CI = 0.75–43.32])—see Table 3 above.
Table 4

Results of multivariate logistic regression of factors associated with increased IES-R scores.

Logistic parameterIES-R scores
  M OR CI p
Sex (female)27--0.0001
Direct exposure to infected patients-5.622.10–15.030.001
Relative infected by COVID-19-3.911.13–13.500.031

Note. M = Median IES-R score, OR = Odds Ratio, CI = 95% confidence interval, IES-R = Impact of Event Scale–Revised.

IES-R scores of Female and Male participants were compared and then adjusted using Wilcoxon rank sum test (Male Median = 19).

Note. M = Median IES-R score, OR = Odds Ratio, CI = 95% confidence interval, IES-R = Impact of Event Scale–Revised. IES-R scores of Female and Male participants were compared and then adjusted using Wilcoxon rank sum test (Male Median = 19). Among occupational factors, direct exposure to infected patients was associated with higher IES-R scores. When compared to professionals who were not directly exposed, those who had a direct exposure were more likely to achieve higher scores, with an OR = 5.62 (p = 0.001, 95% CI = 2.10–15.03). Those findings are presented in Table 4.

Associations with substance abuse

Results indicate that, according to the ASSIST 2.0 form, 24.7% of ICU workers had scores suggestive of alcohol abuse. Scores compatible with tobacco abuse and dependence were seen in 11.2% and 2.3%, respectively. Eighteen workers (4.8%) had scores compatible with hypnotics abuse. There was no statistically significant association between personal or occupational factors and substance use. However, two association trends were found. For tobacco and alcohol, higher scores had an association trend towards history of psychiatric disease, direct exposure to infected patients and those who sought alternative accommodation away from home during the pandemic in order to protect their relatives. For cannabis, stimulants, and cocaine, higher scores had an association trend towards history of psychiatric disease and direct exposure to infected patients. The prevalence of each substance use is detailed on Table 5 below.
Table 5

Prevalence of substance use according to the ASSIST 2.0 categories.

Baseline characteristicSuggestive of Substance AbuseSuggestive of Substance Dependence
  n % n %
Tobacco4211.282.1
Alcohol9324.700
Cannabis 51.300
Cocaine 0000
Stimulants 20.500
Inhaled drugs0000
Hypnotics184.810.3
Hallucinogens10.300
Opioids20.500
Intravenous drugs30.800
Other drugs10.300

Note. N = 376 (total number of participants); n = number of participants within the subgroup.

ASSIST 2.0 = Alcohol, Smoking and Substance Involvement Screening Test (version 2.0); scores were categorized according to the clinical interpretation of the results.

*Categories: 0–3 = occasional substance use; 4–15 = suggestive of substance abuse; ≥16 = suggestive of substance dependence [15].

Note. N = 376 (total number of participants); n = number of participants within the subgroup. ASSIST 2.0 = Alcohol, Smoking and Substance Involvement Screening Test (version 2.0); scores were categorized according to the clinical interpretation of the results. *Categories: 0–3 = occasional substance use; 4–15 = suggestive of substance abuse; ≥16 = suggestive of substance dependence [15].

Discussion

This research found associations between participants’ personal and occupational factors and signs of ASD/PTSD in a COVID-19 ICU in this Brazilian hospital. Sex (female), direct exposure to infected patients and having a relative infected by COVID-19 were significantly associated with higher IES-R scores. Other factors such as history of psychiatric disease, history of anxiety disorders, and seeking alternative accommodation away from home during the pandemic were assessed but did not present a statistically significant association with higher IES-R scores. The prevalence of alcohol and tobacco abuse was high. The evaluation of substance use among ICU workers with the ASSIST 2.0 form was not able to determine any statistically significant associations with personal or occupational factors and higher scores. Nonetheless, there was an association trend towards tobacco, alcohol, cannabis, stimulants, and cocaine use in those with a history of psychiatric disease and with direct exposure to infected patients. In a recent study evaluating the mental health of ICU workers in England [19], authors found similar results, with high prevalence of traumatic stress disorders and alcohol abuse, especially among nurses (which account for the most numerous subpopulation of the presenting study). We believe that those factors associated with higher IES-R scores were directly related to an increased stress load in those individuals. Whilst the cause is unclear, it could be suggested that, when compared to most of the occupational factors, personal life characteristics, as well as direct exposure to infected patients, were more strongly related to the likelihood of having PTSD or ASD symptoms. Researchers investigating the impact of personal and occupational factors on the mental health of Canadian ICU workers exposed to COVID-19 infected patients found that, following a multivariate analysis, those elements related to the anxiety about being infected during work were the best predictors of scores indicative of traumatic stress disorders [20]. We further hypothesize that worrying about the safety of their relatives is another possible cause of this overwhelming stress. In terms of substance use, the most frequently consumed were tobacco and alcohol. Those were also the substances with higher frequencies of abuse and dependence. It is possible that those results reflected the availability of those substances. Also, the abusive consumption of those substances could be a coping mechanism during the pandemic. Even considering the socio-cultural differences among countries, the current results are in accordance with those presented by other authors, in other populations of ICU workers (e.g., Netherlands [4], Canada [20], United States [21], and England [19]). Thus, it is likely that the findings of the presenting study could be generalizable to ICU workers from different populations and should be taken into consideration by professionals working globally. This study has several limitations. Firstly, as reported and studied in the field of substance abuse, this study may be subject to social desirability bias, which is the tendency of a participant providing answers based on what is considered a desired behavior within a specific socio-cultural environment [22, 23]. The fear of being treated with prejudice by their peers may also be a contributing factor for this bias in ICU workers [24]. Secondly, some ICU staff during the application of this study either refused to participate or were on medical leave. Given that some of those workers may have had psychological or psychiatric reasons for work leave, our findings can be underestimated. Thirdly, the lack of statistical significance could be due to a small sample size in some sub-groups and thus statistical testing lacked power. However, with regards to the non-statistically significant results, we believe they should be taken into account because it is reasonable to hypothesize that some of those factors may also contribute to the psychological burden in the ICU workers. Fourthly, this study had no follow-up sessions. Therefore, it was not possible to determine causal relationships or risk factors. Finally, it was a single-centered research and, therefore, influenced by local environmental biases. Nevertheless, our sample was large enough to find some statistically significant associations between participants characteristics and the development of PTSD/ASD symptoms during the COVID-19 pandemic. It was also possible to highlight the alarming prevalence of substance use among those individuals, which may carry devastating consequences for their personal and professional lives. Considering the duration and the consequences of the COVID-19 pandemic, specifically for the population of this study, our results should bring to light the need for institutional support for those individuals. From the experiences with the severe acute respiratory syndrome virus (SARS) outbreak in the early 2000’s, it has been demonstrated that ICU professionals may need long term support for mental health issues developed during their work time with infected patients [25]. As recently proposed by other authors [26, 27], intervention plans should be traced not only during the pandemic but also after it, due to the prolonged course of diseases such as PTSD, ASD, and SA. For that reason, we believe that this study could be used for guiding larger, multicenter studies and institutional interventions to prevent and reduce the suffering of professionals dealing with similar situations in Brazil and in other countries.

Personal and occupational information (English version).

(DOCX) Click here for additional data file.

Personal and occupational information (Portuguese version).

(DOCX) Click here for additional data file.

ASSIST 2.0 (English version).

(DOCX) Click here for additional data file.

ASSIST 2.0 (Portuguese version).

(DOCX) Click here for additional data file.

IES-R (English version).

(DOCX) Click here for additional data file.

IES-R (Portuguese version).

(DOCX) Click here for additional data file.

Minimal anonymized data set (English [translation]).

(XLSX) Click here for additional data file.

Minimal anonymized data set (Portuguese [original]).

(XLSX) Click here for additional data file. 15 Oct 2021
PONE-D-21-17265
Stress and Substance Abuse among workers during the COVID-19 Pandemic in an Intensive Care Unit: a cross-sectional study. PLOS ONE Dear Dr. Pestana, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript has been evaluated by three reviewers, and their comments are available below. The reviewers have raised a number of concerns that need attention, and they request additional information on methodological aspects of the study and the analyses, and they have requested additional contextualization and revisions to the language usage. Could you please revise the manuscript to carefully address the concerns raised? Please submit your revised manuscript by Nov 28 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Vanessa Carels Staff Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The study provides findings on an important topic that is of concern during this pandemic. Nonetheless, there are several major amendments that will need to be made before it can be considered for publication. 1. I am not certain that the claim the authors make about how there are only a few research studies that have examined the occurrence of mental health problems in healthcare workers working in the ICU during the pandemic is valid. From what I understand, this topic has garnered a lot of interest and there is substantial literature that has emerged since the pandemic. Perhaps it may be more appropriate to limit this statement to the context of Brazil. 2. Although the discussion does follow from the findings of the analysis, there is a lack of reference to existing literature about the topic. Authors should attempt to use existing literature to support their conclusions, or to posit reasons for their findings. Similarly, the limitations section suggests that participants may have been afraid of suffering retaliation, leading to report bias. Reasons for this should be provided in greater detail, or citations for studies that have looked into this phenomenon should be given. Lastly, the section on practical implications of this study should have references to studies that have highlighted the importance of institutional support and/or long term intervention plans. 3. The appropriate statistical methods were chosen. 4. The authors are unable to make the data publicly available due to its sensitive nature, but it is available upon reasonable request. 5. The language errors make it difficult to understand at times, and the awkward expression of certain terms may cause readers to misunderstand what the authors are trying to convey. e.g "licensed from work" -- I believe the authors were trying to say that these healthcare workers were absent from work? "Although most of them shared their homes with individuals with greater risk for severe infection, only 21% of them left home during the pandemic" -- It is unclear why or how these individuals are at greater risk of severe infection. Do you mean to say they belong to a vulnerable population (e.g chronic illnesses/elderly)? The term "left home" should be more appropriately expressed as "sought alternative accommodation away from home". "However, with regards to the non-statistically significant associations, we believe they should be taken into account because of the biological plausibility they carry within them." -- Am not sure what biological plausibility means in this context "Pharmaceuticals" -- I believe it should be "pharmacists" 6. Other comments: - The abstract should not contain abbreviations that have not been spelled out in full at first mention. - Please provide a citation for the way the IES-R and ASSIST 2.0 scores were categorized. Are there scoring guidelines available? - Please refer to a standardized format (e.g APA) for the presentation of data in tables. The way it is currently organized can be confusing for readers. Also, all abbreviations in tables and its title (e.g ICU, IES-R) should be explained in the footnotes. Reviewer #2: The study is interesting but is single-centre. There is no comparison between the different critical care professions. The authors do not report anxiety or depression scores. Finally, the authors did not go into enough depth in their analyses. Reviewer #3: The title is accurate or relevant The aims of the study are clearly stated The study is original The study is useful and relevant to the aims of the Journal The design of the study is appropriate The sample size, selection and composition are appropriate Methods used to collect data (e.g. validated questionnaires and instruments, observational techniques) are appropriate Qualitative or quantitative methods used to analyse the data are appropriate Details of the methods (including settings and locations, procedures, dates of recruitment and follow-up or main outcomes) are clearly reported The data are less than 5 years old The study was approved by a research ethics committee prior to data collection Participants were asked for informed consent prior to data collection or informed consent was not required The qualitative or quantitative analyses were applied appropriately Missing data, e.g. non-respondents, drop-outs or non-responses, have been accounted for The results are clearly presented and explained No further qualitative or quantitative analysis is required The authors reflect on the strengths and limitations of the study The results are compared to related findings in the literature The results are discussed in relation to the relevant research, practice or policy issues The discussion and conclusions do not speculate beyond what has been shown in this study The article has a logical construction in a suitable format The article has an appropriate length (not unnecessarily long or too short to be useful) The writing is in a good standard of English, grammatically correct and easy to understand The abstract is in an unstructured format and is sufficiently informative Any tables and figures are all necessary, clearly annotated and easy to follow ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Modesto Leite Rolim Neto - Faculdade de Medicina - Universidade Federal do Cariri - UFCA [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 27 Nov 2021 Response to the Editor and Reviewers Dear Reviewers and Dr. Carels (Editorial Board of PLOS One). We are pleased to share with you our response to the comments made regarding our manuscript entitled “Stress and Substance Abuse among workers during the COVID-19 Pandemic in an Intensive Care Unit: a cross-sectional study”. We hope that our replies can properly address the issues highlighted by you. Thank you for your attention to this. Sincerely, Diego V. S. Pestana (on behalf of the authors) Comments – Editor: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf Author’s Reply: Dear Dr. Carels, thank you for your help during this process and for your important comments. The manuscript has been edited to meet PLOS ONE’s requirements. We conducted a thorough review of the requirements and we believe that the manuscript now completely meets the publishing requirements. Also, we reviewed the text once more in search for eventual typos or misspellings that may have been unnoticed so far. Finally, as mentioned below in one of the replies, the text has been reviewed by 2 independent native English speakers to improve the quality the written English used on it and facilitate readers understanding. Nevertheless, if you or the reviewers happen to have any other suggestion regarding this topic, we will be glad to work on it. 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. Author’s Reply: We apologize for the inconvenience regarding this topic. As suggested, we uploaded 6 files as Supporting Information, accounting for each one of the components of the questionnaire used in this project (the ASSIST 2.0, the IES-R, and the questions regarding personal and occupational information developed by our research group) and both, an English and a Portuguese version of them. 3 & 4 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Author’s Reply: Thank you for your guidance over this topic. As mentioned, we had not submitted the data set along with the other files given it involves information of sensitive nature. Nevertheless, after carefully reviewing PLOS ONE’s data policy, we believe that it is reasonable to share the data set, as it has no legal or ethical restrictions and can be publicly available as the minimal anonymized data set. In that way, data can be safely shared with readers without harming participants privacy. Comments - Reviewer #1 The study provides findings on an important topic that is of concern during this pandemic. Nonetheless, there are several major amendments that will need to be made before it can be considered for publication. 1. I am not certain that the claim the authors make about how there are only a few research studies that have examined the occurrence of mental health problems in healthcare workers working in the ICU during the pandemic is valid. From what I understand, this topic has garnered a lot of interest and there is substantial literature that has emerged since the pandemic. Perhaps it may be more appropriate to limit this statement to the context of Brazil. Author’s Reply: Dear Reviewer 1, thank you for your valuable comments! Indeed, within the last months several articles have been published, most of them exploring the consequences of the COVID-19 pandemic to the mental health of health care professionals working in ICUs. After carefully considering this comment, we conducted another search on literature, focusing on those evaluating Brazilian ICU workers. Our findings and conclusions are summarized below: #1: Most of these articles approach mental health issues on Brazilian physicians and nursing staff. The present article evaluates not only physicians, but also all the nursing staff, physiotherapy professionals, nutritional professionals, cleaning staff, maintenance staff, administrative staff, and security staff. We believe that all of these professionals are essential to provide adequate conditions for an ICU, and, therefore, this would be an interesting feature of the present article. #2: We used different searching methods and sources in order to identify other articles that evaluated the impact of COVID-19 on Brazilian ICU workers, specifically on the issue of substance abuse. Also, the presenting manuscript evaluated several personal and/or occupational characteristics rarely found in other studies of this nature However, we were not able to find any other study addressing these concerns in the studied population (Brazilian ICU workers). Therefore, we believe that this aspect would also provide scientifically relevant information to readers of PLOS One. #3: We agree with your comment, and our manuscript has been properly changed to provide more accurate information. The reviewed version limits its claims to Brazilian ICU workers. 2. Although the discussion does follow from the findings of the analysis, there is a lack of reference to existing literature about the topic. Authors should attempt to use existing literature to support their conclusions, or to posit reasons for their findings. Similarly, the limitations section suggests that participants may have been afraid of suffering retaliation, leading to report bias. Reasons for this should be provided in greater detail, or citations for studies that have looked into this phenomenon should be given. Lastly, the section on practical implications of this study should have references to studies that have highlighted the importance of institutional support and/or long term intervention plans. Author’s Reply: After carefully considering this comment, we reviewed our Discussion section. While reviewing it, we also searched for references that support the points highlighted in this comment. Below we addressed each point made in the comment above, using references that illustrate the topic under discussion. #1: The concern about mental health among ICU workers during the COVID-19 pandemic has been widely studied within the last 2 years [1.1], [1.2], [1.3]. In a study with a structure similar to the one used in the present manuscript, with similar studied populations, Greenberg et al (2021) [1.4] identified alarmingly high prevalence of post-traumatic stress disorder symptoms, depressive symptoms, and signs of alcohol abuse among participants. Even before the COVID-19 pandemic, both substance abuse [1.5], [1.6] and traumatic stress disorders [1.7] were identified as being serious problems among healthcare professionals, often more intensely present in subspecialties such as Anesthesiology, Emergency Care, and Critical Care. Therefore, we believe that the findings reported in the present manuscript are in accordance with what could be expected, based on the pre-existing literature on this topic. Also, although we present novel scientific data, the pre-existing literature seems to support our findings and conclusions. We are thankful for this suggestion, and the Discussion section of the presenting manuscript has been properly adjusted after it. #2: Substance abuse is a sensitive topic, often associated with stigmatization. Even in the context of healthcare, when it comes to individuals suffering with substance abuse, providers may act based on prejudice, as described by Stone et al (2021) [2.1]. This phenomenon may be associated with another factor known as “social desirability bias”, often described in self-report studies regarding substance abuse. According to Latkins et al (2017) [2.2]: “Social desirability bias is the tendency to underreport socially undesirable attitudes and behaviors and to over report more desirable attributes”. Early in the study of social desirability bias, Welte et al (1993) [2.3] concluded that “social desirability response bias probably results in underestimates of rates of heavy drinking and drug use” in self-reported studies. After reviewing these concepts and searching deeper into the literature, we believe that the Discussion section of our manuscript should approach the aforementioned sources of bias using the term “social desirability bias” instead of “report bias”. Accordingly, we re-wrote this section using the proper terminology and adjusting it to the proper phenomena described. Of note, there were no reports or any signs of retaliation during this study, and the incorporation of this element to the manuscript was a result of our misinterpretation of the involved biases. #3: In terms of background, from the experiences with the 2003 SARS outbreaks, Maunder et al (2006) [3.1] demonstrated that healthcare providers are found to have an increased risk of developing mental health problems following a contagious disease pandemic. The awareness of this potential issue stimulated researchers worldwide to investigate the need for psychosocial support to healthcare workers, specifically those working at ICUs. Among recently published studies regarding the COVID-19 pandemic, Roberts et al (2021) [3.2] highlighted the importance of supporting ICU workers to prevent and/or diminish the harms involved with mental health issues in this population, claiming that "It is also clear that psychological support and services for nurses and the wider healthcare team need to be available and quickly convened in the event of similar major incidents, either global or local" [3.2]. Finally, the British Medical Journal published an article from their own authorship stressing the need for psychosocial support to these workers [3.3]. Those were only a couple of illustrative examples among several other articles our team was able to find. Therefore, we believe that it is possible to claim that other studies and/or authors also highlighted the importance of institutional support and/or long-term intervention plans. We were happy to incorporate the aforementioned topics into the Discussion section of the presenting manuscript. REFERENCES [1.1] Kok, N., van Gurp, J., Teerenstra, S., van der Hoeven, H., Fuchs, M., Hoedemaekers, C., & Zegers, M. (2021). Coronavirus Disease 2019 Immediately Increases Burnout Symptoms in ICU Professionals: A Longitudinal Cohort Study. Critical care medicine, 49(3), 419–427. https://doi.org/10.1097/CCM.0000000000004865 [1.2] Binnie, A., Moura, K., Moura, C., D'Aragon, F., & Tsang, J. (2021). Psychosocial distress amongst Canadian intensive care unit healthcare workers during the acceleration phase of the COVID-19 pandemic. PloS one, 16(8), e0254708. https://doi.org/10.1371/journal.pone.0254708 [1.3] Danet Danet A. (2021). Psychological impact of COVID-19 pandemic in Western frontline healthcare professionals. A systematic review. Impacto psicológico de la COVID-19 en profesionales sanitarios de primera línea en el ámbito occidental. Una revisión sistemática. Medicina clinica, 156(9), 449–458. https://doi.org/10.1016/j.medcli.2020.11.009 [1.4] Greenberg, N., Weston, D., Hall, C., Caulfield, T., Williamson, V., & Fong, K. (2021). Mental health of staff working in intensive care during Covid-19. Occupational medicine (Oxford, England), 71(2), 62–67. https://doi.org/10.1093/occmed/kqaa220 [1.5] Bryson, E. O., & Silverstein, J. H. (2008). Addiction and substance abuse in anesthesiology. Anesthesiology, 109(5), 905–917. https://doi.org/10.1097/ALN.0b013e3181895bc1 [1.6] Baldisseri M. R. (2007). Impaired healthcare professional. Critical care medicine, 35(2 Suppl), S106–S116. https://doi.org/10.1097/01.CCM.0000252918.87746.96 [1.7] Rodríguez-Rey, R., Palacios, A., Alonso-Tapia, J., Pérez, E., Álvarez, E., Coca, A., Mencía, S., Marcos, A., Mayordomo-Colunga, J., Fernández, F., Gómez, F., Cruz, J., Ordóñez, O., & Llorente, A. (2019). Burnout and posttraumatic stress in paediatric critical care personnel: Prediction from resilience and coping styles. Australian critical care : official journal of the Confederation of Australian Critical Care Nurses, 32(1), 46–53. https://doi.org/10.1016/j.aucc.2018.02.003 [2.1] Stone, E. M., Kennedy-Hendricks, A., Barry, C. L., Bachhuber, M. A., & McGinty, E. E. (2021). The role of stigma in U.S. primary care physicians' treatment of opioid use disorder. Drug and alcohol dependence, 221, 108627. https://doi.org/10.1016/j.drugalcdep.2021.108627 [2.2] Latkin, C. A., Edwards, C., Davey-Rothwell, M. A., & Tobin, K. E. (2017). The relationship between social desirability bias and self-reports of health, substance use, and social network factors among urban substance users in Baltimore, Maryland. Addictive behaviors, 73, 133–136. https://doi.org/10.1016/j.addbeh.2017.05.005 [2.3] Welte, J. W., & Russell, M. (1993). Influence of socially desirable responding in a study of stress and substance abuse. Alcoholism, clinical and experimental research, 17(4), 758–761. https://doi.org/10.1111/j.1530-0277.1993.tb00836.x [3.1]Maunder, R. G., Lancee, W. J., Balderson, K. E., Bennett, J. P., Borgundvaag, B., Evans, S., Fernandes, C. M., Goldbloom, D. S., Gupta, M., Hunter, J. J., McGillis Hall, L., Nagle, L. M., Pain, C., Peczeniuk, S. S., Raymond, G., Read, N., Rourke, S. B., Steinberg, R. J., Stewart, T. E., VanDeVelde-Coke, S., … Wasylenki, D. A. (2006). Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak. Emerging infectious diseases, 12(12), 1924–1932. https://doi.org/10.3201/eid1212.060584 [3.2]Roberts, N. J., Kelly, C. A., Lippiett, K. A., Ray, E., & Welch, L. (2021). Experiences of nurses caring for respiratory patients during the first wave of the COVID-19 pandemic: an online survey study. BMJ open respiratory research, 8(1), e000987. https://doi.org/10.1136/bmjresp-2021-000987 [3.3] What organisations around the world are doing to help improve doctors’ wellbeing BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1541 3. The appropriate statistical methods were chosen. Author’s Reply: None. 4. The authors are unable to make the data publicly available due to its sensitive nature, but it is available upon reasonable request. Author’s Reply: None. 5. The language errors make it difficult to understand at times, and the awkward expression of certain terms may cause readers to misunderstand what the authors are trying to convey. e.g: "licensed from work" -- I believe the authors were trying to say that these healthcare workers were absent from work? "Although most of them shared their homes with individuals with greater risk for severe infection, only 21% of them left home during the pandemic" -- It is unclear why or how these individuals are at greater risk of severe infection. Do you mean to say they belong to a vulnerable population (e.g chronic illnesses/elderly)? The term "left home" should be more appropriately expressed as "sought alternative accommodation away from home". "However, with regards to the non-statistically significant associations, we believe they should be taken into account because of the biological plausibility they carry within them." -- Am not sure what biological plausibility means in this context "Pharmaceuticals" -- I believe it should be "pharmacists" Author’s Reply: We appreciate the suggestions made regarding the proper use of the English language. They were incorporated into the manuscript. Also, as an attempt to improve the quality of the text, two native English speaker biomedical scientists, by any means involved with this project, blindly and independently reviewed the text, and further suggestions were also incorporated to improve the overall quality of the text. 6. Other comments: - The abstract should not contain abbreviations that have not been spelled out in full at first mention. Author’s Reply: the abstract has been re-write without abbreviations and with a clearer language. - Please provide a citation for the way the IES-R and ASSIST 2.0 scores were categorized. Are there scoring guidelines available? Author’s Reply: #1 IES-R: the citation for the score categorization of the IES-R can be found below; note that we used the most recent version of the tool which was validated to the Brazilian population. In the manuscript we included the original citation as well as the citation for the validation study. REFERENCE [4.1] Weiss, D.S. (2007). The Impact of Event Scale: Revised. In J.P. Wilson & C.S. Tang (Eds.), Cross-cultural assessment of psychological trauma and PTSD (pp. 219-238). New York: Springer. #2 ASSIST 2.0: the citation below refers to the article led by the World Health Organization (WHO), in which it is possible to find the interpretation for the scoring categories of the ASSIST tool. Similarly to the IES-R, we selected the most updated version of the ASSIST questionnaire which was validated to the Brazilian population. REFERENCE [4.2] WHO ASSIST Working Group (2002). The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction (Abingdon, England), 97(9), 1183–1194. https://doi.org/10.1046/j.1360-0443.2002.00185.x As suggested, both references were properly incorporated to the manuscript. - Please refer to a standardized format (e.g APA) for the presentation of data in tables. The way it is currently organized can be confusing for readers. Also, all abbreviations in tables and its title (e.g ICU, IES-R) should be explained in the footnotes. Author’s Reply: Tables were properly formatted according to the APA Publishing Manual (7th edition), and footnotes now describe all abbreviations used; also, explanations regarding the presented variables were provided whenever needed, to facilitate interpretation by readers. Comments - Reviewer #2 The study is interesting but is single-centre. Author’s Reply: Dear Reviewer #2, thank you for your valuable comments! We agree with you in the sense that being a single-centre project is a limitation of the presenting study. Collaborations with other institutions were discussed, but due to logistical constraints, we could not perform a multi-centre project. Nevertheless, we believe that this study has been done over solid methodological basis, which may account for its internal validity. Also, although the studied population is from Brazil, our results are in accordance with results from studies conducted in different countries, which may indicate that the presenting study also has appreciable external validity. There is no comparison between the different critical care professions. Author’s Reply: We are glad you mentioned this issue, as this has been discussed within our research group. On the contrary of what we expected to see, there was no significant difference in the scores among the various critical care professions. We hypothesize that this may be due to lack of statistical power. Interestingly, the larger group in the study sample accounts for nurses and nursing assistants, which, again, is in accordance with which has been found by other similar studies conducted in other countries. Thus, the present study may help to demonstrate that larger sample sizes may be required to evaluate differences in the stress burden among the various professions involved in running an ICU; alternatively, the results presented in this study may also suggest that profession per se is not independently associated with higher risks of developing traumatic stress disorders and/or substance abuse. The authors do not report anxiety or depression scores. Author’s Reply: We appreciate your attention to this detail. Indeed, anxiety and depression have been recurrently reported as common mental health problems among ICU workers. During the development of the research question for this study, we conducted a thorough literature review, and we identified a significant gap in the knowledge regarding substance abuse and traumatic stress disorders in the studied population. Thus, although we were aware that depression and anxiety disorders could also be elevated in the studied population, we aimed to explore other severe comorbidities, trying to fill a specific knowledge gap previously identified by our literature review. Finally, the authors did not go into enough depth in their analyses. Author’s Reply: Dear Reviewer #2, we are sorry to hear that. While planning this project, we tried to build a strong investigation, deep enough to contribute with our scientific community in this moment of collective efforts. We understand the limitations of the study, but we hope that, as a result of this manuscript, ICU workers can benefit from better institutional support. Nonetheless, we appreciate your comments and suggestions, and we believe they have helped to improve this manuscript. Comments - Reviewer #3 The title is accurate or relevant. The aims of the study are clearly stated. The study is original. The study is useful and relevant to the aims of the Journal. The design of the study is appropriate. The sample size, selection and composition are appropriate. Methods used to collect data (e.g. validated questionnaires and instruments, observational techniques) are appropriate. Qualitative or quantitative methods used to analyse the data are appropriate. Details of the methods (including settings and locations, procedures, dates of recruitment and follow-up or main outcomes) are clearly reported. The data are less than 5 years old. The study was approved by a research ethics committee prior to data collection. Participants were asked for informed consent prior to data collection or informed consent was not required. The qualitative or quantitative analyses were applied appropriately. Missing data, e.g. non-respondents, drop-outs or non-responses, have been accounted for. The results are clearly presented and explained. No further qualitative or quantitative analysis is required. The authors reflect on the strengths and limitations of the study. The results are compared to related findings in the literature. The results are discussed in relation to the relevant research, practice or policy issues. The discussion and conclusions do not speculate beyond what has been shown in this study. The article has a logical construction in a suitable format. The article has an appropriate length (not unnecessarily long or too short to be useful). The writing is in a good standard of English, grammatically correct and easy to understand. The abstract is in an unstructured format and is sufficiently informative. Any tables and figures are all necessary, clearly annotated and easy to follow. Author’s Reply: Dear Reviewer #3, we were extremely happy to receive your comments. Thank you for your time and consideration while evaluating our manuscript, we really appreciate it. Submitted filename: Response to Reviewers.docx Click here for additional data file. 14 Dec 2021
PONE-D-21-17265R1
Stress and Substance Abuse among workers during the COVID-19 Pandemic in an Intensive Care Unit: a cross-sectional study.
PLOS ONE Dear Dr. Pestana, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 28 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Sanjay Kumar Singh Patel, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I thank the authors for careful consideration of my previous comments. I am largely satisfied with the revisions made, but still have a few areas of concern as highlighted below: 1. In the Results section, Paragraph on "Psychiatric Medical History", I believe the p-values reported are erroneous. It should be p = .034 and p = .044. Similarly, the p-values in Table 3.2 will need to be checked again to ensure that they correspond to the text. 2. There are still issues with the language in multiple areas, although I greatly appreciate the effort undertaken by the authors to improve the language of the manuscript thus far. Some examples include: - [Incomplete sentence] "All the professionals working at an oncological COVID-19 ICU, regardless of their role (health professionals and non-health professionals), who were on duty for at least during one shift through the period of July to October/2020." - [Error indicated in caps] "Professionals with infected relatives .... significantly more likely to score higher in the IES-R, therefore more likely to suffer WITH PTSD or ASD." - [Error indicated in caps] "There was an association trend between higher scores and those who had sought alternative accommodation AWAY FROM during the pandemic ...." - [Error indicated in caps] "For cannabis, stimulants, and cocaine, higher scores had an ... direct EXPOSITION to infected patients." - [Error indicated in caps] "It is possible that those results REFLEX the availability of those substances." - ["Provided that" should be replaced with "GIVEN that some of those workers MAY HAVE HAD.."] Provided that some of those workers had psychological or psychiatric reasons for work leave, our findings can be underestimated. - [Should be phrased as "study had no FOLLOW-UP sessions] "Fourthly, as a cross-sectional study, it was not possible to determine causal relationships nor risk factors and the participants were not followed." 3. Minor suggestion to change the header "ASSIST 2.0 Results" to "Associations with substance abuse" instead. 4. Please provide the citation for the cut-off points/categorization of IES and ASSIST 2.0 scores after listing the cut-offs in order to allow readers to easily search for the original paper that provides these cut-offs. i.e "The IES-R scores were categorized as follows: 1-11 = few/no signs of ASD/PTSD; 12-32 = several signs of ASD/PTSD, patient monitoring is recommended; ≥33 = highly suggestive of ASD/PTSD, immediate psychiatric evaluation is recommended [INSERT CITATION HERE]." 5. Authors should consider elaborating a little on how their findings may be generalizable to ICUs outside Brazil. A suggestion is given below. "the current results are in accordance those presented by other authors, in other populations of ICU workers (e.g., Netherlands [4], Canada [20], United States [21], and England [19]), suggesting that findings from this study are applicable and should be taken into consideration by professionals working in ICUs globally." Reviewer #2: The authors have responded in a satisfactory manner to all comments. I have no additional comments to make. Reviewer #3: The design of the study is appropriate The writing is in a good standard of English, grammatically correct and easy to understand The results are clearly presented and explained [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
24 Jan 2022 Response to the Editor and Reviewers Dear Reviewers and Dr. Patel (Editorial Board of PLOS One). We are pleased to share with you our response to the comments made regarding our manuscript entitled “Stress and Substance Abuse among workers during the COVID-19 Pandemic in an Intensive Care Unit: a cross-sectional study”. We hope that our replies can properly address the issues highlighted by you. Thank you for your attention to this. Sincerely, Diego V. S. Pestana (on behalf of the authors) Comments – Editor: 1. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Author’s Reply: Dear Dr. Patel, thank you for your help with this manuscript. We reviewed the reference list completely and, although we could not find any retracted paper, we identified some points that could be optimized, as discussed below (between brackets we informed which action was made regarding each reference). Additionally, we checked all the references to make sure they were available online at their original publisher/journal website, without retraction notes. All references were written according to the Vancouver style, as indicated at PLOS One website. Reference #7: Baldisseri MR. Impaired healthcare professional. Critical Care Medicine. 2007 Feb;35(Suppl):S106–16. [Substitution] Although the article appears after a simple search on PubMed, whenever we tried to access it using the publisher/journal website the link led us to a blank webpage. We searched for retraction notes or such type of publication regarding this paper but there was none. Therefore, we decided to look for a new reference article to substitute it. After reading several other papers, we chose the article below, which also supports what we wrote in the respective excerpt of the presenting manuscript. “DeFord S, Bonom J, Durbin T. A review of literature on substance abuse among anaesthesia providers. Journal of Research in Nursing. 2019 Dec 22;24(8):587–600.” Reference #15: Group WAW. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002 Sep;97(9):1183–94. [Substitution] Although the previous reference also contained information regarding the ASSIST 2.0 tool, interpreting scores based solely on this paper could be difficult for readers. The new reference refers to the manual more recently published on behalf of the World Health Organization and allows readers to quickly find the information to which our study refers. Therefore, we thought it should substitute the former reference. “Humeniuk R, Ali R, Babor TF, Farrell M, Formigoni ML, Jittiwutikarn J, et al. Validation of the alcohol, smoking and substance involvement screening test (ASSIST). Addiction. 2008 Jun;103(6):1039–47.” Reference #17: Weiss DS. The Impact of Event Scale: Revised. In: Wilson JP, Tang CS, editors. Cross-cultural assessment of psychological trauma and PTSD . New York: Springer; 2007. p. 219–38. [Correction] The first citation was incorrect. It improperly mixed information regarding the book and the chapter being cited. We corrected it with the proper citation, as listed below. “Weiss DS. The Impact of Event Scale: Revised. In: Cross-Cultural Assessment of Psychological Trauma and PTSD. Boston, MA: Springer US; p. 219–38.” Comments - Reviewer #1 I thank the authors for careful consideration of my previous comments. I am largely satisfied with the revisions made, but still have a few areas of concern as highlighted below: 1. In the Results section, Paragraph on "Psychiatric Medical History", I believe the p-values reported are erroneous. It should be p = .034 and p = .044. Similarly, the p-values in Table 3.2 will need to be checked again to ensure that they correspond to the text. Author’s Reply: Dear Reviewer #1, thank you for your very constructive comments. After carefully reviewing the paragraph you mentioned, we identified a discordance between the p values presented in the paragraph and in Table 3.1. We reassessed our statistical tests and the correct values are p = 0.341 (history of psychiatric disease) and p = 0.44 (history of anxiety disorders). The values were properly corrected (please find our STATA output below, with the respective p values). Also, we corrected the tables’ titles according to the new order they were cited in the text. Former Table 3.1 was renamed to Table 3.2; former Table 3.2 was renamed to Table 3.1. In this paragraph we highlighted some factors that had exhibited what we considered an association trend towards higher IES-R scores. Although they provided some interesting insights regarding the issues involved with stress and substance abuse among participants, those factors did not achieve statistical significance when considering p <0.05. Therefore, we believe that the terms used to describe those findings should be substituted: we chose “Factors without an association with IES-R scores”. Although the association between those factors and IES-R scores did not achieve statistical significance, the presenting results may still be interesting to readers, and future studies with more statistical power may show different results. Finally, we chose to present those elements in a different table (i.e., Table 3.1) to make sure readers would not confuse them with the ones that achieved statistical significance (i.e., Table 3.2). Finally, we merged the subtopics “Personal factors” and “Occupational factors”, creating a new subtopic entitled “Personal and occupational factors”. We believe that this change made the excerpt conciser to eventual readers. We hope your concerns regarding this topic were properly and satisfactorily addressed. Thank you for your valuable suggestions! 2. There are still issues with the language in multiple areas, although I greatly appreciate the effort undertaken by the authors to improve the language of the manuscript thus far. Author’s Reply: Again, we are pleased to fully accept your suggestions regarding English issues. Below you will find a list with corrections made after your suggestions, following the same order you presented them. We hope those changes shall address your concerns regarding this matter. - [Incomplete sentence] "All the professionals working at an oncological COVID-19 ICU, regardless of their role (health professionals and non-health professionals), who were on duty for at least during one shift through the period of July to October/2020." Author’s Reply: we added the excerpt “were invited to participate in this study” after the sentence mentioned. - [Error indicated in caps] "Professionals with infected relatives .... significantly more likely to score higher in the IES-R, therefore more likely to suffer WITH PTSD or ASD." Author’s Reply: we substituted the word “with” by “from” (i.e., to suffer from PTSD or ASD). - [Error indicated in caps] "There was an association trend between higher scores and those who had sought alternative accommodation AWAY FROM during the pandemic ...." Author’s Reply: we completed the sentence with the word “home” (i.e., away from home during the pandemic). To ensure this error wasn’t present in other similar sentences, we checked the other parts in which this term was used, and they were properly written. - [Error indicated in caps] "For cannabis, stimulants, and cocaine, higher scores had an ... direct EXPOSITION to infected patients." Author’s Reply: we substituted the word “exposition” by “exposure”. Like what we did in the previous suggestion, all other similar excerpts were checked for mistakes, and they were properly written. - [Error indicated in caps] "It is possible that those results REFLEX the availability of those substances." Author’s Reply: we substituted the word “reflex” by “reflected”. No other similar mistakes were found. - ["Provided that" should be replaced with "GIVEN that some of those workers MAY HAVE HAD.."] Provided that some of those workers had psychological or psychiatric reasons for work leave, our findings can be underestimated. Author’s Reply: we replaced the terms as mentioned above. - [Should be phrased as "study had no FOLLOW-UP sessions] "Fourthly, as a cross-sectional study, it was not possible to determine causal relationships nor risk factors and the participants were not followed." Author’s Reply: we rephrased this excerpt as “Fourthly, this study had no follow-up sessions. Therefore, it was not possible to determine causal relationships or risk factors”. 3. Minor suggestion to change the header "ASSIST 2.0 Results" to "Associations with substance abuse" instead. Author’s Reply: we changed the header as suggested; we agree that the suggested version is more suitable to readers. Thank you! 4. Please provide the citation for the cut-off points/categorization of IES and ASSIST 2.0 scores after listing the cut-offs in order to allow readers to easily search for the original paper that provides these cut-offs. i.e "The IES-R scores were categorized as follows: 1-11 = few/no signs of ASD/PTSD; 12-32 = several signs of ASD/PTSD, patient monitoring is recommended; ≥33 = highly suggestive of ASD/PTSD, immediate psychiatric evaluation is recommended [INSERT CITATION HERE]." Author’s Reply: we inserted the respective citations to the IES-R and ASSIST 2.0 scores whenever those categorizations were mentioned. 5. Authors should consider elaborating a little on how their findings may be generalizable to ICUs outside Brazil. A suggestion is given below. "the current results are in accordance those presented by other authors, in other populations of ICU workers (e.g., Netherlands [4], Canada [20], United States [21], and England [19]), suggesting that findings from this study are applicable and should be taken into consideration by professionals working in ICUs globally." Author’s Reply: after reading your suggestion, we added the excerpt “Thus, it is likely that the findings of the presenting study could be generalizable to ICU workers from different populations and should be taken into consideration by professionals working globally”. We agree that such a phrase may clarify the main idea of this paragraph. Thank you! Comments - Reviewer #2 The authors have responded in a satisfactory manner to all comments. I have no additional comments to make. Author’s Reply: We appreciate your attention when reviewing this manuscript. We hope the corrections made after your previous comments had satisfactorily addressed your concerns and improved the quality of the current manuscript. Comments - Reviewer #3 The design of the study is appropriate. The writing is in a good standard of English, grammatically correct and easy to understand. The results are clearly presented and explained. Author’s Reply: We are glad to read your comments to this manuscript, thank you for your help during this review process. Submitted filename: Response to Reviewers.docx Click here for additional data file. 31 Jan 2022 Stress and Substance Abuse among workers during the COVID-19 Pandemic in an Intensive Care Unit: a cross-sectional study. PONE-D-21-17265R2 Dear Dr. Pestana, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sanjay Kumar Singh Patel, Ph.D. Academic Editor PLOS ONE 3 Feb 2022 PONE-D-21-17265R2 Stress and substance abuse among workers during the COVID-19 pandemic in an intensive care unit: a cross-sectional study. Dear Dr. Vinicius Santinelli Pestana: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Sanjay Kumar Singh Patel Academic Editor PLOS ONE
  25 in total

1.  Substance Use in Healthcare Workers: Importance of Stress Perception, Smoking Temptation, Social Support, and Humor.

Authors:  Stephen Daniel Ramos; Morgan Kelly; Ty Schepis
Journal:  Subst Use Misuse       Date:  2017-11-27       Impact factor: 2.164

2.  What organisations around the world are doing to help improve doctors' wellbeing.

Authors:  Abi Rimmer; Cat Chatfield
Journal:  BMJ       Date:  2020-04-17

3.  Coronavirus Disease 2019 Immediately Increases Burnout Symptoms in ICU Professionals: A Longitudinal Cohort Study.

Authors:  Niek Kok; Jelle van Gurp; Steven Teerenstra; Hans van der Hoeven; Malaika Fuchs; Cornelia Hoedemaekers; Marieke Zegers
Journal:  Crit Care Med       Date:  2021-03-01       Impact factor: 7.598

4.  [Validation of the Brazilian version of Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)].

Authors:  Iara Ferraz Silva Henrique; Denise De Micheli; Roseli Boerngen de Lacerda; Luiz Avelino de Lacerda; Maria Lucia Oliveira de Souza Formigoni
Journal:  Rev Assoc Med Bras (1992)       Date:  2004-07-21       Impact factor: 1.209

Review 5.  Addiction and substance abuse in anesthesiology.

Authors:  Ethan O Bryson; Jeffrey H Silverstein
Journal:  Anesthesiology       Date:  2008-11       Impact factor: 7.892

6.  Burnout Among Anesthetists and Intensive Care Physicians.

Authors:  Audrius Mikalauskas; Rimantas Benetis; Edmundas Širvinskas; Judita Andrejaitienė; Šarūnas Kinduris; Andrius Macas; Žilvinas Padaiga
Journal:  Open Med (Wars)       Date:  2018-04-05

7.  Transforming ORs into ICUs.

Authors:  Alexander W Peters; Kashmira S Chawla; Zachary A Turnbull
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

8.  Mental health of staff working in intensive care during Covid-19.

Authors:  N Greenberg; D Weston; C Hall; T Caulfield; V Williamson; K Fong
Journal:  Occup Med (Lond)       Date:  2021-04-09       Impact factor: 1.611

9.  Experiences of nurses caring for respiratory patients during the first wave of the COVID-19 pandemic: an online survey study.

Authors:  Nicola J Roberts; Carol A Kelly; Kate A Lippiett; Emma Ray; Lindsay Welch
Journal:  BMJ Open Respir Res       Date:  2021-07
View more
  2 in total

1.  Occupational stress in industry setting in Benin 2019: A cross-sectional study.

Authors:  Mênonli Adjobimey; Vikkey Hinson; Rose Mikponhoué; Esdras Hountohotegbe; Elvyre Klikpo; Ibrahim Mama Cissé; Amelée Adjogou; Véronique Dossougbété; Jonathon R Campbell; Paul Ayélo; Dismand Houinato
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

2.  Psychological repercussions on nursing staff due to the COVID-19 pandemic: A cross-sectional study.

Authors:  D Martínez-Ponce; M A Amat-Traconis; L Y Cala-Rosabal; E Chapan-Xolio; L Valenzuela-Velázquez; M G Lecourtois-Amézquita
Journal:  J Healthc Qual Res       Date:  2022-08-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.